Martin McMahon, PhD

Title(s)Professor Emeritus, HDF Comprehensive Cancer Ctr
SchoolSchool of Medicine
AddressLocation Required, #001
Varies CA 00000
Phone801-213-5790
ORCID ORCID Icon0000-0003-2812-1042 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPostdoctoral StudiesGraduate Division

    Collapse Research 
    Collapse Research Activities and Funding
    Targeting Oncogenic BRAF And PI3'-Kinase Signaling For Melanoma Therapy
    NIH R01CA176839Apr 1, 2013 - May 31, 2018
    Role: Principal Investigator
    Studying the initiation, progression and therapy of lung cancer in mouse models
    NIH R01CA131261Dec 1, 2007 - Aug 31, 2021
    Role: Principal Investigator
    Regulation of apoptosis by mutationally activated B-Raf
    NIH R01CA108972Apr 1, 2005 - Nov 28, 2010
    Role: Principal Investigator
    Cancer Center Support Grant
    NIH P30CA082103Aug 5, 1999 - May 31, 2023
    Role: Co-Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR Suppression. Mol Cancer Ther. 2024 Mar 04; 23(3):301-315. Parkman GL, Turapov T, Kircher DA, Burnett WJ, Stehn CM, O'Toole K, Culver KM, Chadwick AT, Elmer RC, Flaherty R, Stanley KA, Foth M, Lum DH, Judson-Torres RL, Friend JE, VanBrocklin MW, McMahon M, Holmen SL. PMID: 37931033.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    2. PTEN phosphatase inhibits metastasis by negatively regulating the Entpd5/IGF1R pathway through ATF6. iScience. 2023 Feb 17; 26(2):106070. Yu Y, Dai M, Huang L, Chen W, Yu E, Mendoza A, Michael H, Khanna C, Bosenberg M, McMahon M, Merlino G. PMID: 36824269; PMCID: PMC9942123.
      View in: PubMed   Mentions: 1  
    3. Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis. Cancer Res. 2022 11 15; 82(22):4261-4273. Vaishnavi A, Juan J, Jacob M, Stehn C, Gardner EE, Scherzer MT, Schuman S, Van Veen JE, Murphy B, Hackett CS, Dupuy AJ, Chmura SA, van der Weyden L, Newberg JY, Liu A, Mann K, Rust AG, Weiss WA, Kinsey CG, Adams DJ, Grossmann A, Mann MB, McMahon M. PMID: 36112789; PMCID: PMC9664136.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    4. The role of PI3'-lipid signalling in melanoma initiation, progression and maintenance. Exp Dermatol. 2022 01; 31(1):43-56. Parkman GL, Foth M, Kircher DA, Holmen SL, McMahon M. PMID: 34717019; PMCID: PMC8724390.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    5. Melanoma models for the next generation of therapies. Cancer Cell. 2021 05 10; 39(5):610-631. Patton EE, Mueller KL, Adams DJ, Anandasabapathy N, Aplin AE, Bertolotto C, Bosenberg M, Ceol CJ, Burd CE, Chi P, Herlyn M, Holmen SL, Karreth FA, Kaufman CK, Khan S, Kobold S, Leucci E, Levy C, Lombard DB, Lund AW, Marie KL, Marine JC, Marais R, McMahon M, Robles-Espinoza CD, Ronai ZA, Samuels Y, Soengas MS, Villanueva J, Weeraratna AT, White RM, Yeh I, Zhu J, Zon LI, Hurlbert MS, Merlino G. PMID: 33545064; PMCID: PMC8378471.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimals
    6. Model-dependent outcomes: Sex as a biological variable in preclinical mouse models of melanoma. Pigment Cell Melanoma Res. 2021 05; 34(3):655-658. Parkman GL, Kircher DA, Stehn CM, McMahon M, Holmen SL. PMID: 33098202; PMCID: PMC8052264.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    7. Chloroquine Sensitizes GNAQ/11-mutated Melanoma to MEK1/2 Inhibition. Clin Cancer Res. 2020 12 01; 26(23):6374-6386. Truong A, Yoo JH, Scherzer MT, Sanchez JMS, Dale KJ, Kinsey CG, Richards JR, Shin D, Ghazi PC, Onken MD, Blumer KJ, Odelberg SJ, McMahon M. PMID: 32933997; PMCID: PMC7710560.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    8. Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer. Cell Rep. 2020 08 04; 32(5):107994. Vaishnavi A, Scherzer MT, Kinsey CG, Parkman GL, Truong A, Ghazi P, Schuman S, Battistone B, Garrido-Laguna I, McMahon M. PMID: 32755586; PMCID: PMC7478141.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    9. RAC1mutation is not a predictive biomarker for PI3'-kinase-β-selective pathway-targeted therapy. Pigment Cell Melanoma Res. 2020 09; 33(5):719-730. Foth M, Parkman G, Battistone B, McMahon M. PMID: 32406574.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    10. Mutationally-activated PI3'-kinase-α promotes de-differentiation of lung tumors initiated by the BRAFV600E oncoprotein kinase. Elife. 2019 08 27; 8. van Veen JE, Scherzer M, Boshuizen J, Chu M, Liu A, Landman A, Green S, Trejo C, McMahon M. PMID: 31452510; PMCID: PMC6711745.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    11. AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis. Mol Cancer Res. 2019 09; 17(9):1787-1800. Kircher DA, Trombetti KA, Silvis MR, Parkman GL, Fischer GM, Angel SN, Stehn CM, Strain SC, Grossmann AH, Duffy KL, Boucher KM, McMahon M, Davies MA, Mendoza MC, VanBrocklin MW, Holmen SL. PMID: 31138602; PMCID: PMC6726552.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    12. Publisher Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nat Med. 2019 May; 25(5):861. Kinsey CG, Camolotto SA, Boespflug AM, Guillen KP, Foth M, Truong A, Schuman SS, Shea JE, Seipp MT, Yap JT, Burrell LD, Lum DH, Whisenant JR, Gilcrease GW, Cavalieri CC, Rehbein KM, Cutler SL, Affolter KE, Welm AL, Welm BE, Scaife CL, Snyder EL, McMahon M. PMID: 30918364.
      View in: PubMed   Mentions: 11     Fields:    
    13. Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nat Med. 2019 04; 25(4):620-627. Kinsey CG, Camolotto SA, Boespflug AM, Guillen KP, Foth M, Truong A, Schuman SS, Shea JE, Seipp MT, Yap JT, Burrell LD, Lum DH, Whisenant JR, Gilcrease GW, Cavalieri CC, Rehbein KM, Cutler SL, Affolter KE, Welm AL, Welm BE, Scaife CL, Snyder EL, McMahon M. PMID: 30833748; PMCID: PMC6452642.
      View in: PubMed   Mentions: 298     Fields:    Translation:HumansAnimalsCells
    14. Proceedings of the fifth international RASopathies symposium: When development and cancer intersect. Am J Med Genet A. 2018 12; 176(12):2924-2929. Rauen KA, Schoyer L, Schill L, Stronach B, Albeck J, Andresen BS, Cavé H, Ellis M, Fruchtman SM, Gelb BD, Gibson CC, Gripp K, Hefner E, Huang WYC, Itkin M, Kerr B, Linardic CM, McMahon M, Oberlander B, Perlstein E, Ratner N, Rogers L, Schenck A, Shankar S, Shvartsman S, Stevenson DA, Stites EC, Stork PJS, Sun C, Therrien M, Ullian EM, Widemann BC, Yeh E, Zampino G, Zenker M, Timmer W, McCormick F. PMID: 30302932; PMCID: PMC6312476.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    15. PIK3CA-mutated melanoma cells rely on cooperative signaling through mTORC1/2 for sustained proliferation. Pigment Cell Melanoma Res. 2017 05; 30(3):353-367. Silva JM, Deuker MM, Baguley BC, McMahon M. PMID: 28233937; PMCID: PMC5411292.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    16. BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis. Elife. 2017 01 10; 6. Sakamoto N, Feng Y, Stolfi C, Kurosu Y, Green M, Lin J, Green ME, Sentani K, Yasui W, McMahon M, Hardiman KM, Spence JR, Horita N, Greenson JK, Kuick R, Cho KR, Fearon ER. PMID: 28072391; PMCID: PMC5268782.
      View in: PubMed   Mentions: 47     Fields:    Translation:Animals
    17. Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma model. Oncotarget. 2016 Nov 15; 7(46):75839-75853. Grossauer S, Koeck K, Murphy NE, Meyers ID, Daynac M, Truffaux N, Truong AY, Nicolaides TP, McMahon M, Berger MS, Phillips JJ, James CD, Petritsch CK. PMID: 27713119; PMCID: PMC5342782.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    18. P2A-Fluorophore Tagging of BRAF Tightly Links Expression to Fluorescence In Vivo. PLoS One. 2016; 11(6):e0157661. van Veen JE, Pringle DR, McMahon M. PMID: 27348307; PMCID: PMC4922626.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    19. The state of melanoma: challenges and opportunities. Pigment Cell Melanoma Res. 2016 07; 29(4):404-16. Merlino G, Herlyn M, Fisher DE, Bastian BC, Flaherty KT, Davies MA, Wargo JA, Curiel-Lewandrowski C, Weber MJ, Leachman SA, Soengas MS, McMahon M, Harbour JW, Swetter SM, Aplin AE, Atkins MB, Bosenberg MW, Dummer R, Gershenwald JE, Halpern AC, Herlyn D, Karakousis GC, Kirkwood JM, Krauthammer M, Lo RS, Long GV, McArthur G, Ribas A, Schuchter L, Sosman JA, Smalley KS, Steeg P, Thomas NE, Tsao H, Tueting T, Weeraratna A, Xu G, Lomax R, Martin A, Silverstein S, Turnham T, Ronai ZA. PMID: 27087480; PMCID: PMC5228487.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    20. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis. Cancer Res. 2015 Dec 15; 75(24):5378-91. Green S, Trejo CL, McMahon M. PMID: 26567140; PMCID: PMC4681648.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    21. AKT1 Activation Promotes Development of Melanoma Metastases. Cell Rep. 2015 Nov 03; 13(5):898-905. Cho JH, Robinson JP, Arave RA, Burnett WJ, Kircher DA, Chen G, Davies MA, Grossmann AH, VanBrocklin MW, McMahon M, Holmen SL. PMID: 26565903; PMCID: PMC4646731.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansAnimalsCells
    22. Intermittent dosing in melanoma. Clin Adv Hematol Oncol. 2015 Jun; 13(6):348-50. McMahon M. PMID: 26352888; PMCID: PMC4839533.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    23. TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung Tumorigenesis. Cancer Res. 2015 Aug 01; 75(15):3167-80. Shai A, Dankort D, Juan J, Green S, McMahon M. PMID: 26001956; PMCID: PMC4526430.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    24. Rational targeting of BRAF and PI3-Kinase signaling for melanoma therapy. Mol Cell Oncol. 2016 May; 3(3):e1033095. Deuker MM, McMahon M. PMID: 27314067; PMCID: PMC4909456.
      View in: PubMed   Mentions: 5  
    25. Transposon mutagenesis identifies genetic drivers of Braf(V600E) melanoma. Nat Genet. 2015 May; 47(5):486-95. Mann MB, Black MA, Jones DJ, Ward JM, Yew CC, Newberg JY, Dupuy AJ, Rust AG, Bosenberg MW, McMahon M, Print CG, Copeland NG, Jenkins NA. PMID: 25848750; PMCID: PMC4844184.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    26. The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies. Nat Genet. 2015 Mar; 47(3):250-6. Lin L, Sabnis AJ, Chan E, Olivas V, Cade L, Pazarentzos E, Asthana S, Neel D, Yan JJ, Lu X, Pham L, Wang MM, Karachaliou N, Cao MG, Manzano JL, Ramirez JL, Torres JM, Buttitta F, Rudin CM, Collisson EA, Algazi A, Robinson E, Osman I, Muñoz-Couselo E, Cortes J, Frederick DT, Cooper ZA, McMahon M, Marchetti A, Rosell R, Flaherty KT, Wargo JA, Bivona TG. PMID: 25665005; PMCID: PMC4930244.
      View in: PubMed   Mentions: 274     Fields:    Translation:HumansAnimalsCells
    27. mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation. Cancer Cell. 2015 Jan 12; 27(1):41-56. Damsky W, Micevic G, Meeth K, Muthusamy V, Curley DP, Santhanakrishnan M, Erdelyi I, Platt JT, Huang L, Theodosakis N, Zaidi MR, Tighe S, Davies MA, Dankort D, McMahon M, Merlino G, Bardeesy N, Bosenberg M. PMID: 25584893; PMCID: PMC4295062.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansAnimalsCells
    28. PI3'-kinase inhibition forestalls the onset of MEK1/2 inhibitor resistance in BRAF-mutated melanoma. Cancer Discov. 2015 Feb; 5(2):143-53. Deuker MM, Marsh Durban V, Phillips WA, McMahon M. PMID: 25472943; PMCID: PMC4320669.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimalsCells
    29. Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond. Nat Rev Cancer. 2014 Jul; 14(7):455-67. Holderfield M, Deuker MM, McCormick F, McMahon M. PMID: 24957944; PMCID: PMC4250230.
      View in: PubMed   Mentions: 368     Fields:    Translation:HumansAnimals
    30. Cancer biology: Enzyme meets a surprise target. Nature. 2014 Jun 12; 510(7504):225-6. Deuker MM, McMahon M. PMID: 24847879; PMCID: PMC4250228.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    31. Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade. Cancer Immunol Res. 2014 Jul; 2(7):643-54. Cooper ZA, Juneja VR, Sage PT, Frederick DT, Piris A, Mitra D, Lo JA, Hodi FS, Freeman GJ, Bosenberg MW, McMahon M, Flaherty KT, Fisher DE, Sharpe AH, Wargo JA. PMID: 24903021; PMCID: PMC4097121.
      View in: PubMed   Mentions: 132     Fields:    Translation:HumansAnimalsCells
    32. Activating BRAF and PIK3CA mutations cooperate to promote anaplastic thyroid carcinogenesis. Mol Cancer Res. 2014 Jul; 12(7):979-86. Charles RP, Silva J, Iezza G, Phillips WA, McMahon M. PMID: 24770869; PMCID: PMC4635659.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansAnimals
    33. Isolation and molecular characterization of circulating melanoma cells. Cell Rep. 2014 May 08; 7(3):645-53. Luo X, Mitra D, Sullivan RJ, Wittner BS, Kimura AM, Pan S, Hoang MP, Brannigan BW, Lawrence DP, Flaherty KT, Sequist LV, McMahon M, Bosenberg MW, Stott SL, Ting DT, Ramaswamy S, Toner M, Fisher DE, Maheswaran S, Haber DA. PMID: 24746818; PMCID: PMC4079008.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimalsCells
    34. p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer. Proc Natl Acad Sci U S A. 2014 Apr 22; 111(16):E1600-9. McFadden DG, Vernon A, Santiago PM, Martinez-McFaline R, Bhutkar A, Crowley DM, McMahon M, Sadow PM, Jacks T. PMID: 24711431; PMCID: PMC4000830.
      View in: PubMed   Mentions: 89     Fields:    Translation:HumansAnimalsCells
    35. Diminished WNT -> β-catenin -> c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors. Genes Dev. 2014 Mar 15; 28(6):561-75. Juan J, Muraguchi T, Iezza G, Sears RC, McMahon M. PMID: 24589553; PMCID: PMC3967046.
      View in: PubMed   Mentions: 44     Fields:    Translation:AnimalsCells
    36. The fastest Western in town: a contemporary twist on the classic Western blot analysis. J Vis Exp. 2014 Feb 05; (84):e51149. Silva JM, McMahon M. PMID: 24561642; PMCID: PMC4028330.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    37. BRAFV600E cooperates with PI3K signaling, independent of AKT, to regulate melanoma cell proliferation. Mol Cancer Res. 2014 Mar; 12(3):447-63. Silva JM, Bulman C, McMahon M. PMID: 24425783; PMCID: PMC3966216.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    38. Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma. J Clin Invest. 2013 Dec; 123(12):5104-18. Marsh Durban V, Deuker MM, Bosenberg MW, Phillips W, McMahon M. PMID: 24200692; PMCID: PMC3859393.
      View in: PubMed   Mentions: 43     Fields:    
    39. Hematopoietic expression of oncogenic BRAF promotes aberrant growth of monocyte-lineage cells resistant to PLX4720. Mol Cancer Res. 2013 Dec; 11(12):1530-41. Kamata T, Dankort D, Kang J, Giblett S, Pritchard CA, McMahon M, Leavitt AD. PMID: 24152792; PMCID: PMC3869667.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    40. Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma. Proc Natl Acad Sci U S A. 2013 Nov 05; 110(45):18226-31. Yuan P, Ito K, Perez-Lorenzo R, Del Guzzo C, Lee JH, Shen CH, Bosenberg MW, McMahon M, Cantley LC, Zheng B. PMID: 24145418; PMCID: PMC3831456.
      View in: PubMed   Mentions: 128     Fields:    Translation:Animals
    41. Abnormal Ras signaling in Costello syndrome (CS) negatively regulates enamel formation. Hum Mol Genet. 2014 Feb 01; 23(3):682-92. Goodwin AF, Tidyman WE, Jheon AH, Sharir A, Zheng X, Charles C, Fagin JA, McMahon M, Diekwisch TG, Ganss B, Rauen KA, Klein OD. PMID: 24057668; PMCID: PMC3888259.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    42. Mutationally activated PIK3CA(H1047R) cooperates with BRAF(V600E) to promote lung cancer progression. Cancer Res. 2013 Nov 01; 73(21):6448-61. Trejo CL, Green S, Marsh V, Collisson EA, Iezza G, Phillips WA, McMahon M. PMID: 24019382; PMCID: PMC3825323.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCells
    43. Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov. 2013 Nov; 3(11):1272-85. Strohecker AM, Guo JY, Karsli-Uzunbas G, Price SM, Chen GJ, Mathew R, McMahon M, White E. PMID: 23965987; PMCID: PMC3823822.
      View in: PubMed   Mentions: 240     Fields:    Translation:HumansAnimalsCells
    44. Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance. Nature. 2013 Feb 14; 494(7436):251-5. Das Thakur M, Salangsang F, Landman AS, Sellers WR, Pryer NK, Levesque MP, Dummer R, McMahon M, Stuart DD. PMID: 23302800; PMCID: PMC3930354.
      View in: PubMed   Mentions: 385     Fields:    Translation:HumansAnimalsCells
    45. Elucidating distinct roles for NF1 in melanomagenesis. Cancer Discov. 2013 Mar; 3(3):338-49. Maertens O, Johnson B, Hollstein P, Frederick DT, Cooper ZA, Messiaen L, Bronson RT, McMahon M, Granter S, Flaherty K, Wargo JA, Marais R, Cichowski K. PMID: 23171796; PMCID: PMC3595355.
      View in: PubMed   Mentions: 117     Fields:    Translation:HumansAnimalsCells
    46. Oncogene-dependent control of miRNA biogenesis and metastatic progression in a model of undifferentiated pleomorphic sarcoma. J Pathol. 2013 Jan; 229(1):132-40. Mito JK, Min HD, Ma Y, Carter JE, Brigman BE, Dodd L, Dankort D, McMahon M, Kirsch DG. PMID: 22951975; PMCID: PMC3552559.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCells
    47. An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature. 2012 Nov 15; 491(7424):449-53. Mitra D, Luo X, Morgan A, Wang J, Hoang MP, Lo J, Guerrero CR, Lennerz JK, Mihm MC, Wargo JA, Robinson KC, Devi SP, Vanover JC, D'Orazio JA, McMahon M, Bosenberg MW, Haigis KM, Haber DA, Wang Y, Fisher DE. PMID: 23123854; PMCID: PMC3521494.
      View in: PubMed   Mentions: 182     Fields:    Translation:AnimalsCells
    48. The intermediate-activity (L597V)BRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathway. Genes Dev. 2012 Sep 01; 26(17):1945-58. Andreadi C, Cheung LK, Giblett S, Patel B, Jin H, Mercer K, Kamata T, Lee P, Williams A, McMahon M, Marais R, Pritchard C. PMID: 22892241; PMCID: PMC3435497.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    49. B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancer. Cancer Res. 2012 Sep 15; 72(18):4765-76. Wang J, Kobayashi T, Floc'h N, Kinkade CW, Aytes A, Dankort D, Lefebvre C, Mitrofanova A, Cardiff RD, McMahon M, Califano A, Shen MM, Abate-Shen C. PMID: 22836754; PMCID: PMC3445712.
      View in: PubMed   Mentions: 64     Fields:    Translation:AnimalsCells
    50. Analysis of mRNA profiles after MEK1/2 inhibition in human pancreatic cancer cell lines reveals pathways involved in drug sensitivity. Mol Cancer Res. 2012 Dec; 10(12):1607-19. Gysin S, Paquette J, McMahon M. PMID: 22833572; PMCID: PMC4261949.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    51. Regulated temporal-spatial astrocyte precursor cell proliferation involves BRAF signalling in mammalian spinal cord. Development. 2012 Jul; 139(14):2477-87. Tien AC, Tsai HH, Molofsky AV, McMahon M, Foo LC, Kaul A, Dougherty JD, Heintz N, Gutmann DH, Barres BA, Rowitch DH. PMID: 22675209; PMCID: PMC3383225.
      View in: PubMed   Mentions: 67     Fields:    Translation:AnimalsCells
    52. A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinoma. Cancer Discov. 2012 Aug; 2(8):685-93. Collisson EA, Trejo CL, Silva JM, Gu S, Korkola JE, Heiser LM, Charles RP, Rabinovich BA, Hann B, Dankort D, Spellman PT, Phillips WA, Gray JW, McMahon M. PMID: 22628411; PMCID: PMC3425446.
      View in: PubMed   Mentions: 149     Fields:    Translation:HumansAnimalsCells
    53. Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy. Proc Natl Acad Sci U S A. 2012 May 29; 109(22):8710-5. Huillard E, Hashizume R, Phillips JJ, Griveau A, Ihrie RA, Aoki Y, Nicolaides T, Perry A, Waldman T, McMahon M, Weiss WA, Petritsch C, James CD, Rowitch DH. PMID: 22586120; PMCID: PMC3365162.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimalsCells
    54. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis. Genes Dev. 2012 May 15; 26(10):1055-69. Vredeveld LC, Possik PA, Smit MA, Meissl K, Michaloglou C, Horlings HM, Ajouaou A, Kortman PC, Dankort D, McMahon M, Mooi WJ, Peeper DS. PMID: 22549727; PMCID: PMC3360561.
      View in: PubMed   Mentions: 142     Fields:    Translation:HumansCells
    55. E-cadherin regulates the behavior and fate of epithelial stem cells and their progeny in the mouse incisor. Dev Biol. 2012 Jun 15; 366(2):357-66. Li CY, Cha W, Luder HU, Charles RP, McMahon M, Mitsiadis TA, Klein OD. PMID: 22537490; PMCID: PMC3690274.
      View in: PubMed   Mentions: 36     Fields:    Translation:AnimalsCells
    56. MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E. Cancer Res. 2012 Jun 15; 72(12):3048-59. Trejo CL, Juan J, Vicent S, Sweet-Cordero A, McMahon M. PMID: 22511580; PMCID: PMC3393094.
      View in: PubMed   Mentions: 29     Fields:    Translation:AnimalsCells
    57. β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. Cancer Cell. 2011 Dec 13; 20(6):741-54. Damsky WE, Curley DP, Santhanakrishnan M, Rosenbaum LE, Platt JT, Gould Rothberg BE, Taketo MM, Dankort D, Rimm DL, McMahon M, Bosenberg M. PMID: 22172720; PMCID: PMC3241928.
      View in: PubMed   Mentions: 186     Fields:    Translation:HumansAnimalsCells
    58. Control of mitotic spindle angle by the RAS-regulated ERK1/2 pathway determines lung tube shape. Science. 2011 Jul 15; 333(6040):342-345. Tang N, Marshall WF, McMahon M, Metzger RJ, Martin GR. PMID: 21764747; PMCID: PMC4260627.
      View in: PubMed   Mentions: 95     Fields:    Translation:AnimalsCells
    59. Mutationally activated BRAF(V600E) elicits papillary thyroid cancer in the adult mouse. Cancer Res. 2011 Jun 01; 71(11):3863-71. Charles RP, Iezza G, Amendola E, Dankort D, McMahon M. PMID: 21512141; PMCID: PMC3107361.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimalsCells
    60. Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies. Am J Med Genet C Semin Med Genet. 2011 May 15; 157C(2):136-46. Rauen KA, Banerjee A, Bishop WR, Lauchle JO, McCormick F, McMahon M, Melese T, Munster PN, Nadaf S, Packer RJ, Sebolt-Leopold J, Viskochil DH. PMID: 21495172; PMCID: PMC4145816.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    61. Parsing out the complexity of RAF inhibitor resistance. Pigment Cell Melanoma Res. 2011 Apr; 24(2):361-5. McMahon M. PMID: 21392366; PMCID: PMC3075071.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    62. RAF translocations expand cancer targets. Nat Med. 2010 Jul; 16(7):749-50. McMahon M. PMID: 20613748; PMCID: PMC4263025.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    63. Resiliency and vulnerability in the HER2-HER3 tumorigenic driver. Sci Transl Med. 2010 Jan 27; 2(16):16ra7. Amin DN, Sergina N, Ahuja D, McMahon M, Blair JA, Wang D, Hann B, Koch KM, Shokat KM, Moasser MM. PMID: 20371474; PMCID: PMC3033659.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansAnimalsCells
    64. Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back. Am J Med Genet A. 2010 Jan; 152A(1):4-24. Rauen KA, Schoyer L, McCormick F, Lin AE, Allanson JE, Stevenson DA, Gripp KW, Neri G, Carey JC, Legius E, Tartaglia M, Schubbert S, Roberts AE, Gelb BD, Shannon K, Gutmann DH, McMahon M, Guerra C, Fagin JA, Yu B, Aoki Y, Neel BG, Balmain A, Drake RR, Nolan GP, Zenker M, Bollag G, Sebolt-Leopold J, Gibbs JB, Silva AJ, Patton EE, Viskochil DH, Kieran MW, Korf BR, Hagerman RJ, Packer RJ, Melese T. PMID: 20014119; PMCID: PMC4051786.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    65. Characterization of melanoma cells capable of propagating tumors from a single cell. Cancer Res. 2010 Jan 01; 70(1):388-97. Held MA, Curley DP, Dankort D, McMahon M, Muthusamy V, Bosenberg MW. PMID: 20048081; PMCID: PMC4026296.
      View in: PubMed   Mentions: 49     Fields:    Translation:AnimalsCells
    66. Down-regulation of Cdx2 in colorectal carcinoma cells by the Raf-MEK-ERK 1/2 pathway. Cell Signal. 2009 Dec; 21(12):1846-56. Krueger F, Madeja Z, Hemberger M, McMahon M, Cook SJ, Gaunt SJ. PMID: 19686845; PMCID: PMC4625762.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    67. Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008. Pigment Cell Melanoma Res. 2009 Oct; 22(5):532-43. Agarwala SS, Becker JC, Eggermont AM, Flaherty KT, Garbe C, Goldstein AM, Halpern A, Kashani-Sabet M, Hauschild A, Kirkwood JM, Leachman S, Lorigan P, McMahon M, Messina J, Ribas A, Samlowski WE, Schadendorf D, Sondak VK. PMID: 19659612.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    68. Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet. 2009 May; 41(5):544-52. Dankort D, Curley DP, Cartlidge RA, Nelson B, Karnezis AN, Damsky WE, You MJ, DePinho RA, McMahon M, Bosenberg M. PMID: 19282848; PMCID: PMC2705918.
      View in: PubMed   Mentions: 595     Fields:    Translation:AnimalsCells
    69. Meeting report: fourth international congress of the Society for Melanoma Research. Pigment Cell Melanoma Res. 2008 Feb; 21(1):15-26. Fisher DE, Medrano EE, McMahon M, Soengas MS, Schuchter L, Wolchok JD, Merlino G. PMID: 18353140.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    70. Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival. Pigment Cell Melanoma Res. 2008 Oct; 21(5):534-44. Cartlidge RA, Thomas GR, Cagnol S, Jong KA, Molton SA, Finch AJ, McMahon M. PMID: 18715233; PMCID: PMC4916913.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansAnimalsCells
    71. A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev. 2007 Feb 15; 21(4):379-84. Dankort D, Filenova E, Collado M, Serrano M, Jones K, McMahon M. PMID: 17299132; PMCID: PMC1804325.
      View in: PubMed   Mentions: 256     Fields:    Translation:Animals
    72. A model of intussusceptive angiogenesis. Novartis Found Symp. 2007; 283:37-42; discussion 42-5, 238-41. Levin M, Ewald AJ, McMahon M, Werb Z, Mostov K. PMID: 18300412.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    73. Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells. Proc Natl Acad Sci U S A. 2006 Feb 28; 103(9):3274-9. Banerjee A, Gugasyan R, McMahon M, Gerondakis S. PMID: 16484370; PMCID: PMC1413910.
      View in: PubMed   Mentions: 68     Fields:    Translation:AnimalsCells
    74. Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation. Cancer Res. 2005 Nov 01; 65(21):9643-50. Brandts CH, Sargin B, Rode M, Biermann C, Lindtner B, Schwäble J, Buerger H, Müller-Tidow C, Choudhary C, McMahon M, Berdel WE, Serve H. PMID: 16266983.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansAnimalsCells
    75. Analysis of genomic DNA alterations and mRNA expression patterns in a panel of human pancreatic cancer cell lines. Genes Chromosomes Cancer. 2005 Sep; 44(1):37-51. Gysin S, Rickert P, Kastury K, McMahon M. PMID: 15929091.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    76. Conditional EGFR promotes cell cycle progression and prevention of apoptosis in the absence of autocrine cytokines. Cell Cycle. 2005 Jun; 4(6):822-30. Shelton JG, Steelman LS, Abrams SL, White ER, Akula SM, Franklin RA, Bertrand FE, McMahon M, McCubrey JA. PMID: 15917660.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    77. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1. Cancer Res. 2005 Jun 01; 65(11):4870-80. Gysin S, Lee SH, Dean NM, McMahon M. PMID: 15930308.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    78. Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor. Mol Cell Biol. 2005 Jan; 25(1):220-32. Sreeramaneni R, Chaudhry A, McMahon M, Sherr CJ, Inoue K. PMID: 15601844; PMCID: PMC538777.
      View in: PubMed   Mentions: 68     Fields:    Translation:AnimalsCells
    79. Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT. Mol Cell Biol. 2004 Dec; 24(24):10868-81. Mirza AM, Gysin S, Malek N, Nakayama K, Roberts JM, McMahon M. PMID: 15572689; PMCID: PMC533961.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimalsCells
    80. Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells. Oncogene. 2004 Oct 14; 23(47):7810-20. McCubrey JA, Shelton JG, Steelman LS, Franklin RA, Sreevalsan T, McMahon M. PMID: 15361836.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    81. Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J Biol Chem. 2004 Jul 09; 279(28):28880-8. Silletti S, Yebra M, Perez B, Cirulli V, McMahon M, Montgomery AM. PMID: 15128735.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimalsCells
    82. Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf. J Clin Invest. 2004 Feb; 113(4):539-50. Bergo MO, Gavino BJ, Hong C, Beigneux AP, McMahon M, Casey PJ, Young SG. PMID: 14966563; PMCID: PMC338259.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansAnimalsCells
    83. DeltaRaf-1:ER* bypasses the cyclic AMP block of extracellular signal-regulated kinase 1 and 2 activation but not CDK2 activation or cell cycle reentry. Mol Cell Biol. 2003 Dec; 23(24):9303-17. Balmanno K, Millar T, McMahon M, Cook SJ. PMID: 14645540; PMCID: PMC309715.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    84. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature. 2003 Oct 23; 425(6960):851-6. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernández-del Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL, Hebrok M. PMID: 14520413; PMCID: PMC3688051.
      View in: PubMed   Mentions: 565     Fields:    Translation:HumansAnimalsCells
    85. Ras-induced serine phosphorylation of the focal adhesion protein paxillin is mediated by the Raf-->MEK-->ERK pathway. Exp Cell Res. 2003 Jul 15; 287(2):325-38. Woodrow MA, Woods D, Cherwinski HM, Stokoe D, McMahon M. PMID: 12837288.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    86. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells. Cancer Res. 2003 May 01; 63(9):2088-95. Anders M, Christian C, McMahon M, McCormick F, Korn WM. PMID: 12727824.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    87. Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells. Oncogene. 2003 Apr 24; 22(16):2478-92. Shelton JG, Steelman LS, Lee JT, Knapp SL, Blalock WL, Moye PW, Franklin RA, Pohnert SC, Mirza AM, McMahon M, McCubrey JA. PMID: 12717425.
      View in: PubMed   Mentions: 32     Fields:    Translation:AnimalsCells
    88. Induction of tubulogenesis in telomerase-immortalized human microvascular endothelial cells by glioblastoma cells. Exp Cell Res. 2002 Feb 01; 273(1):21-33. Venetsanakos E, Mirza A, Fanton C, Romanov SR, Tlsty T, McMahon M. PMID: 11795943.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Martin's Networks
    Concepts (478)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (44)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.